Insulin Delivery Devices Market Growth 2022-2028: Increasing Awareness Of Insulin Delivery Devices, And Ongoing Research And Development Activities In The Field

The global insulin delivery devices market to reach USD 33.19 Billion by 2028 at a CAGR of 9.31%, according to the latest report by Reports and Data.

The global insulin delivery devices market to reach USD 33.19 Billion by 2028 at a CAGR of 9.31%, according to the latest report by Reports and Data. Increasing incidences of diabetes, advancement in healthcare infrastructure, and increasing adoption and demand of insulin delivery devices for diabetic care, are some key factors expected to drive market revenue growth over the forecast period. Rapidly increasing geriatric population in developing countries, is further drive the market growth.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1748

According to recent survey, about 463 million people across the world are suffering from diabetes. Approximately 4.2 million deaths are due to this chronic disorder every year impacting heart, kidneys and liver. Improper secretion of naturally occurring hormone, insulin leads to development of diabetes. Insulin delivery devices allow insulin to enter into the bloodstream of diabetic patients non-invasively. Insulin delivery devices becomes necessity of patients suffering through type-1 diabetes. There are various types of delivery devices like insulin pens, syringes, inhalers, pumps, injectors, etc. Ongoing research to design and manufacture advanced products has projected the market growth.

Rising diabetic population in developing countries, and awareness of using innovative insulin delivery devices are some key factors expected to boost market revenue growth over the forecast period. There are lucrative opportunities for the market contributors operating in the global insulin delivery devices market. Increasing government spending on healthcare infrastructure, and favourable reimbursement policies are contributing to market growth going ahead. However, high costs, lack of awareness, and stringent government regulations regarding insulin delivery devices, are the major factors expected to hamper the global insulin delivery devices market growth to a certain extent over the forecast period.

Some Key Highlights from the Report:

    • Insulin pens segment is expected to account for a largest revenue share in the global market. Increasing adoption and popularity of insulin pens is due to its convenience, user-friendliness, and accuracy. Key market manufacturers are focusing on production of advanced products such as, smart insulin pens to meet the increasing demand from diabetic patients.
    • Homecare segment is expected to register robust revenue in the global market over the forecast period due to increasing awareness of using portable insulin delivery devices at home. Diabetes care at home using these use-friendly insulin devices is extremely beneficial for elderly people, reducing trouble of going to hospitals and clinics.
    • North America region is expected to account for a largest revenue share in the global insulin delivery market during the forecast period. The factor responsible for the market growth is increasing prevalence of diabetes due to obesity, unhealthy eating habits, and lack of physical exercise. Moreover, advanced healthcare infrastructure, Increasing knowledge about insulin devices, and favorable reimbursement policies are also contributing to the market growth.
    • Asia Pacific market revenue is expected to expand significantly over the forecast period due to growing geriatric population, rising number of diabetic population, growing awareness about insulin delivery devices. In addition, presence of key manufacturers of insulin delivery devices, is the factor responsible for the market growth.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.

Top Companies Profiled in the Report:

Sanofi Diabetes, Novo Nordisk, Omnipod Insulin Management, Eli Lilly and Company, Gerresheimer, Johnson and Johnson, Becton Dickinson, and Company, F. Hoffmann-La Roche AG, B.Braun, Tandem Diabetes Care, Biocon Limited, and Medtronic Plc.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/insulin-delivery-devices-market

Insulin Delivery Devices Market Segmentation:

Type Outlook (Revenue, USD Billion; 2018 – 2028)

  • Insulin Syringe
  • Insulin Pens
  • Disposables
  • Reusable
  • Insulin Jet Injectors
  • Insulin Pumps
  • Tethered
  • Patch
  • Insulin Needles
  • Insulin Inhalers
  • External Insulin
  • Implantable Insulin

Distribution Channels Outlook (Revenue, USD Billion; 2018 – 2028)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

Ask for Customized Research Report @ https://www.reportsanddata.com/request-customization-form/1748

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data::

Lithium Therapy Market Size, Share And Industry Analysis By Product Type (Generic, Branded), By Dosage Form (Capsule, Solution, Tablet, Extended Release, Tablet), By Distribution Channel (Hospital & Clinic Pharmacies, Online-Retail Pharmacies, Offline-Retail Pharmacies) And Region, Segment Forecasts To 2027

Roadside Drug Testing Devices Market By Device Type (Breathalyzer, Intoxilyzer), By Sales Channel (Online, Stores), By Technology (Fuel Cell, Semiconductor Oxide Sensor), By End-Users (Highway Police, Drug Enforcement Agencies) And Segment Forecasts, 2016-2026

Medical Display Market Size, Share, Growth By Display Resolution (2MP, 2.1MP to 4MP), By Sales Channel (Online, Stores), By Technology (CCFL Based LED, OLED), By Form Factor (Color, Multimodality System), By Display Size (Below 23 Inches), By End-Users (Hospitals, ASC) And Segment Forecasts To 2027

Infusion Therapy Market By Disease Type, By Therapy Type, By Product Type And By End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Home Care, Others), Forecasts To 2027

Ascorbic Acid Market By Type (Sodium Ascorbate, Calcium Ascorbate, Potassium Ascorbate, Magnesium Ascorbate, and Others), By Grade (Pharmaceutical Grade, Food Grade), By Form (Tablet, Tonic, Injection), By Application (Pharmaceutical & Nutraceuticals, Food and Beverages, Personal Care, and Others), and By Region

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs